個(gè)人品牌修煉ABC-浙江銘生
方旭:一個(gè)律師的理想信念-浙江銘生
筆記:如何追加轉(zhuǎn)讓股權(quán)的未出資股東為被執(zhí)行人
生命中無(wú)法缺失的父愛(婚姻家庭)
律師提示:如何應(yīng)對(duì)婚前財(cái)產(chǎn)約定
搞垮一個(gè)事務(wù)所的辦法有很多,辦好一個(gè)事務(wù)所的方法卻只有一個(gè)
顛覆認(rèn)知:語(yǔ)文數(shù)學(xué)總共考了96分的人生會(huì)怎樣?
寧波律師陳春香:爆款作品創(chuàng)作者如何提醒網(wǎng)絡(luò)言論的邊界意識(shí)
搖號(hào)成功選房后還可以后悔要求退還意向金嗎
誤以為“低成本、高回報(bào)”的假離婚,多少人誤入歧途
Angiotensin I Converting Enzyme (ACE-2), also called ACEH (ACE homologue), is a dimeric, zinc-dependent metalloprotease of the ACE family that also includes somatic and germinal ACE. ACE-2 mRNA is found at high levels in heart, testis, and kidney and at lower levels in a wide variety of tissues. ACE-2 is the SARS-CoV and SARS-CoV2 Spike protein receptor in vivo, functions catalytically as a carboxypeptidase to cleave several substrates including angiotensins I and II, and acts as a partner for B0AT1-family amino acid transporters. Through these functions, ACE-2 has been shown to be involved in several diseases including SARS, COVID19, acute lung injury, heart disease, liver and lung fibrosis, inflammatory lung disease, and cardiopulmonary disease . Full length ACE-2 protein includes an extracellular region composed of a single N-terminal peptidase domain and C-terminal collectrin-like domain (CLD), a transmembrane domain, and a short cytoplasmic tail. The N-terminal peptidase region is required for binding to SARS-CoV and SARS-CoV2 spike proteins, while the CLD contains a region that promotes dimerization and association with amino acid transporters.[Tyr1]-MIF-1配方:溶解于20 mM PBS, pH 7.4, 130 mM NaCl溶液中,并經(jīng)0.22μm過(guò)濾后凍干而成。Recombinant Human Kremen-1 Protein,hFc Tag
Recombinant Biotinylated Human KIR2DL1 Protein,His-Avi Tag性能參數(shù)分子別名(Synonyms)CD158A;CD158Ankat1;cl-42表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)BiotinylatedHumanKIR2DL1ProteinisexpressedfromHEK293withHistagandAvitagattheC-Terminus.ItcontainsHis22-Arg242.[Accession|P43626]分子量大?。∕olecularWeight)TheproteinhasapredictedMWof27.1kDa.Duetoglycosylation,theproteinmigratesto48-60kDabasedonSDS-PAGEresult.(Endotoxin)Lessthan1EUperμgbytheLALmethod.純度(Purity)>95%asdeterminedbySDS-PAGEandHPLC.制劑(Formulation)Lyophilizedfrom0.22μmfilteredsolutioninPBS(pH7.4).Normally8%trehaloseisaddedasprotectantbeforelyophilization.重構(gòu)方法(Reconstitution)Centrifugethetubebeforeopening.Reconstitutingtoaconcentrationmorethan100μg/mlisrecommended.Dissolvethelyophilizedproteinindistilledwater.Recombinant Biotinylated Human SEZ6 Protein,His-Avi Tageotaxin-2還具有抑制髓樣細(xì)胞增殖的能力,髓樣細(xì)胞增殖是Eotaxin不共有的生物學(xué)功能。
IdeSProtease全稱免疫球蛋白G降解酶(ImmunoglubulinG-degradingenzymeofStreptococcuspyogenes,IdeS),是由人類致病菌釀膿鏈球菌(Streptococcuspyogenes)產(chǎn)生并分泌至胞外的一種半胱氨酸水解酶。該蛋白酶具有極高的底物特異性,能識(shí)別IgG,在抗體下鉸鏈區(qū)的特定位點(diǎn)進(jìn)行酶切,使IgG水解為完整的F(ab’)2片段和Fc片段。IdeS可識(shí)別人源和其他多種動(dòng)物來(lái)源的IgG,比如人、兔、猴、綿羊以及人動(dòng)物嵌合IgG等。IdeS具有獨(dú)特的底物選擇性,可以作為工具酶應(yīng)用于抗體類藥物或抗體融合蛋白藥物的結(jié)構(gòu)表征分析。本產(chǎn)品利用大腸桿菌重組表達(dá),純度高,具有良好的酶切活性,是用于表征抗體、Fc融合蛋白和抗體-藥物復(fù)合物的有價(jià)值的工具。產(chǎn)品信息規(guī)格2000U/5000U產(chǎn)品性質(zhì)中文別名(Chinesesynonym)免疫球蛋白G降解酶英文別名(Englishsynonym)IdeSProtease來(lái)源(Source)大腸桿菌表達(dá)標(biāo)簽(label)N-terminalHisTag純度(Purity)經(jīng)SDS-PAGE及HPLC分析,純度>95%分子量(Molecularweight)35.3kDa緩沖液組分(Buffer)50mM磷酸鈉,150mMNaCl(pH6.6),50%glycerol
糖苷酶F(PNGaseF)是一種酰胺水解酶,經(jīng)過(guò)和平空間站伊麗莎菌克隆,主要由腦膜炎膿桿菌等革蘭氏陰性菌分泌。N-糖苷酶F(PNGaseF)在酵母中重組表達(dá)(比活性:100000U/mL),可以裂解由天冬酰胺連接的高甘露糖、雜合和復(fù)雜的寡糖糖蛋白。PNGaseF的切割位點(diǎn)為糖蛋白內(nèi)側(cè)N-乙酰葡萄糖胺(GlcNAc)和天冬酰氨殘基之間的酰胺鍵,同時(shí)將酶解后蛋白上的天冬氨酰轉(zhuǎn)化為天冬氨酸。本產(chǎn)品帶his標(biāo)簽,常應(yīng)用于抗體及其相關(guān)蛋白完全去糖基化。另外,我司還提供其他類型的糖苷酶,包括酵母重組表達(dá)的N-糖苷酶F(比活性:750000U/mL),內(nèi)切糖苷酶H,內(nèi)切糖苷酶S。產(chǎn)品信息產(chǎn)品性質(zhì)中文別名(Chinesesynonym)N-糖酰胺酶F;N-糖苷酶F英文別名(Englishsynonym)PNGaseF來(lái)源(Source)酵母重組表達(dá)分子量(Molecularweight)36kDa比活性(Specificactivity)100000U/mL緩沖液組分(Buffer)20mMTris-HClpH7.5,50mMNaCl,5mMEDTA,50%GlycerolSUMO蛋白酶識(shí)別完整的含有100個(gè)氨基酸的SUMO標(biāo)簽蛋白,并能高效地把SUMO從融合蛋白上切割下來(lái)。
ERBB3,又稱HH3(人表皮生長(zhǎng)因子受體3),是一種I型膜糖蛋白,是酪氨酸激酶受體ERBC家族的成員。ERBP家族成員作為表皮生長(zhǎng)因子(LU)家族的生長(zhǎng)因子的受體。在ERBP家庭成員中,因?yàn)樗幸粋€(gè)缺陷的激酶域。ERBB3在角化細(xì)胞、黑色素細(xì)胞、骨骼肌細(xì)胞、成肌細(xì)胞和雪旺細(xì)胞中都有表達(dá)。單體ERbb3是一種低親和性的受體。ERBB3與ERBB2的異聚反應(yīng)形成高親和性受體復(fù)合物。與此相反,ERBB3同向聚合或異向聚合形成了一個(gè)低親和性的結(jié)合物。因?yàn)镋RBB3含有一個(gè)有缺陷的激酶域,ERBB2的激酶域負(fù)責(zé)通過(guò)異二重瓣受體啟動(dòng)酪氨酸磷酸化信號(hào)。研究發(fā)現(xiàn),ERBB3細(xì)胞質(zhì)區(qū)內(nèi)的三個(gè)離散氨基酸信號(hào)對(duì)ERBB2的轉(zhuǎn)導(dǎo)至關(guān)重要。ERBB3的細(xì)胞質(zhì)域也包含6個(gè)一致的結(jié)合主題,用于調(diào)節(jié)P85磷酸酶3激酶(PI3K)的HS2領(lǐng)域,以及一個(gè)豐富的一致的結(jié)合主題。ERBB3的細(xì)胞質(zhì)域也包含6個(gè)一致的結(jié)合主題,用于調(diào)節(jié)P85磷酸酶3激酶(PI3K)的HS2領(lǐng)域,以及一個(gè)豐富的一致的結(jié)合主題。ERBB3的細(xì)胞質(zhì)域也包含6個(gè)一致的結(jié)合主題,用于調(diào)節(jié)P85磷酸酶3激酶(PI3K)的HS2領(lǐng)域,以及一個(gè)豐富的一致的結(jié)合主題。表達(dá)區(qū)間及表達(dá)系統(tǒng)重組的人HR3/ERBB3蛋白表達(dá)自于C-端的HK293細(xì)胞和AVI標(biāo)記。里面有血清20-Thr643。分子量大約71.6PreScission Protease是一種由人鼻病毒14型的3C蛋白酶(human rhinovirus)和GST組成的融合蛋白。Recombinant Human CD38(His Tag)
(CDNF)也是一種新型神經(jīng)營(yíng)養(yǎng)因子,對(duì)多巴胺能神經(jīng)元的強(qiáng)大活性,與神經(jīng)膠質(zhì)細(xì)胞系衍生的(GDNF)相當(dāng)。Recombinant Human Kremen-1 Protein,hFc Tag
Trop-2,alsoknownasepithelialglycoprotein-1antigen(EGP-1),isaproteinthatinhumansisencodedbytheTACSTD2gene.Mutationsofthisgeneresultingelatinousdrop-likecornealdystrophy,anautosomalrecessivedisordercharacterizedbyseverecornealamyloidosisleadingtoblindness.產(chǎn)品性質(zhì)別名EGP1;EGP-1;TROP2;GA733-1;gp50;T16;TACSTD2;TROP-2;M1S1;TACD2UniprotNo.P09758表達(dá)區(qū)間及表達(dá)系統(tǒng)RecombinantBiotinylatedHumanTROP-2/TACSTD2ProteinisexpressedfromHEK293cellswithHistagandAvitagattheC-terminal.ItcontainsHis27-Thr274.分子量TheproteinhasapredictedMWof30.5kDa.Duetoglycosylation,theproteinmigratesto46-55kDabasedonTris-BisPAGEresult.純度>95%asdeterminedbySDS-PAGEandHPLC活性ELISAData:ImmobilizedAnti-TROP-2Antibody,hFcTagat0.5μg/mL(100μL/well)ontheplate.DoseresponsecurveforBiotinylatedHumanTROP-2,HisTagwiththeEC50of24.1ng/mLdeterminedbyELISA.0EUper1μgoftheproteinbytheLALmethod.制劑Lyophilizedfrom0.22μmfilteredsolutioninPBS(pH7.4).Normally5%trehaloseisaddedasprotectantbeforelyophilization.Recombinant Human Kremen-1 Protein,hFc Tag